Efficacy of IFN-λ1 to protect human airway epithelial cells against human rhinovirus 1B infection

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Gulraiz, Fahad ^a   Bellinghausen, Carla ^a   Dentener, Mieke A ^a   Reynaert, Niki L ^a   Gaajetaan, Giel R ^a   Beuken, Erik V ^a   Rohde, Gernot G ^a   Bruggeman, Cathrien A ^a   Stassen, Frank R ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON RECEPTOR; INTERLEUKIN 29; RECOMBINANT BETA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; RECOMBINANT PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CELL PROTECTION; CELL TYPE; CULTURE MEDIUM; DRUG EFFICACY; EPITHELIUM CELL; GENE DOSAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS 1B; HUMAN TISSUE; NONHUMAN; PROGENY; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; RHINOVIRUS 1B INFECTION; RHINOVIRUS INFECTION; UPREGULATION; BRONCHUS; CELL LINE; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; TIME; VIROLOGY;

ANTIVIRAL AGENTS; BRONCHI; CELL LINE; CYTOPROTECTION; EPITHELIAL CELLS; HUMANS; INTERFERON-BETA; INTERLEUKINS; PICORNAVIRIDAE INFECTIONS; RECOMBINANT PROTEINS; RHINOVIRUS; TIME FACTORS;

EID: 84899667297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095134     Document Type: Article

References (46)

1. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, et al. (2006) Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173: 1114-1121. (Pubitemid 43726892)
2. Akinbami LJ, Moorman JE, Liu X (2011) Asthma prevalence, health care use, and mortality: United States, 2005-2009. Natl Health Stat Report: 1-14.
3. Friedlander SL, Busse WW (2005) The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 116: 267-273. (Pubitemid 41096529)
4. Mallia P, Johnston SL (2006) How viral infections cause exacerbation of airway diseases. Chest 130: 1203-1210. (Pubitemid 44583754)
5. Rohde G, Wiethege A, Borg I, Kauth M, Bauer T, et al. (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58: 37-42. (Pubitemid 36135356)
6. Seemungal TA, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA (2000) Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 16: 677-683.
7. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, et al. (2002) Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359: 831-834. (Pubitemid 34233753)
8. Mallia P, Message SD, Gielen V, Contoli M, Gray K, et al. (2011) Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183: 734-742.
9. Vareille M, Kieninger E, Edwards MR, Regamey N (2011) The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 24: 210-229.
10. Jackson DJ, Johnston SL (2010) The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 125: 1178-1187; quiz 1188-1179.
11. Costa-Pereira AP, Williams TM, Strobl B, Watling D, Briscoe J, et al. (2002) The antiviral response to gamma interferon. J Virol 76: 9060-9068. (Pubitemid 34919864)
12. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, et al. (2006) Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80: 4501-4509.
13. Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS, Jr., et al. (2007) Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 81: 9790-9800. (Pubitemid 350067683)
14. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, et al. (2008) Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4: e1000151.
15. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, et al. (2010) Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 84: 5670-5677.
16. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, et al. (2010) Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84: 11515-11522.
17. Osterlund PI, Pietila TE, Veckman V, Kotenko SV, Julkunen I (2007) IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 179: 3434-3442.
18. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, et al. (1998) Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441: 106-110. (Pubitemid 29012382)
19. Stoltz M, Klingstrom J (2010) Alpha/beta interferon (IFN-alpha/beta)- independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection. J Virol 84: 9140-9148.
20. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, et al. (2005) Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201: 937-947. (Pubitemid 40524463)
21. Traves SL, Proud D (2007) Viral-associated exacerbations of asthma and COPD. Curr Opin Pharmacol 7: 252-258. (Pubitemid 46731192)
22. Gaajetaan GR, Geelen TH, Vernooy JH, Dentener MA, Reynaert NL, et al. (2013) Interferon-beta induces a long-lasting antiviral state in human respiratory epithelial cells. J Infect 66: 163-169.
23. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, et al. (2006) Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12: 1023-1026. (Pubitemid 44353382)
24. Okabayashi T, Kojima T, Masaki T, Yokota S, Imaizumi T, et al. (2011) Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 160: 360-366.
25. van Wetering S, van der Linden AC, van Sterkenburg MA, de Boer WI, Kuijpers AL, et al. (2000) Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol 278: L51-58.
26. Gielen V, Johnston SL, Edwards MR (2010) Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur Respir J 36: 646-654.
27. Boncristiani HF, Rossi RD, Criado MF, Furtado FM, Arruda E (2009) Magnetic purification of biotinylated cDNA removes false priming and ensures strand-specificity of RT-PCR for enteroviral RNAs. J Virol Methods 161: 147-153.
28. Gaajetaan GR, Geelen TH, Grauls GE, Bruggeman CA, Stassen FR (2012) CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNbeta-dependent and -independent way. Antiviral Res 93: 39-47.
29. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. (Pubitemid 351818697)
30. Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47.
31. Hou W, Wang X, Ye L, Zhou L, Yang ZQ, et al. (2009) Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J Virol 83: 3834-3842.
32. Colonne PM, Eremeeva ME, Sahni SK (2011) Beta interferon-mediated activation of signal transducer and activator of transcription protein 1 interferes with Rickettsia conorii replication in human endothelial cells. Infect Immun 79: 3733-3743.
33. Chattoraj SS, Ganesan S, Faris A, Comstock A, Lee WM, et al. (2011) Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells. Infect Immun 79: 4131-4145.
34. Slater L, Bartlett NW, Haas JJ, Zhu J, Message SD, et al. (2010) Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 6: e1001178.
35. Cheng JC, Yeh YJ, Huang YH, Liang KH, Chang ML, et al. (2012) Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C. J Viral Hepat 19: e154-162.
36. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264. (Pubitemid 28411130)
37. Sommereyns C, Paul S, Staeheli P, Michiels T (2008) IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4: e1000017.
38. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77. (Pubitemid 36109115)
39. Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, et al. (2008) IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther 7: 1109-1115.
40. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. (Pubitemid 44739521)
41. Xie RL, Gupta S, Miele A, Shiffman D, Stein JL, et al. (2003) The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter. J Biol Chem 278: 26589-26596. (Pubitemid 36876803)
42. Venkatesh D, Ernandez T, Rosetti F, Batal I, Cullere X, et al. (2013) Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-beta autocrine signaling to promote monocyte recruitment. Immunity 38: 1025-1037.
43. Kotla S, Peng T, Bumgarner RE, Gustin KE (2008) Attenuation of the type I interferon response in cells infected with human rhinovirus. Virology 374: 399-410.
44. Drahos J, Racaniello VR (2009) Cleavage of IPS-1 in cells infected with human rhinovirus. J Virol 83: 11581-11587.
45. Baines KJ, Hsu AC, Tooze M, Gunawardhana LP, Gibson PG, et al. (2013) Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Respir Res 14: 15.
46. Khaitov MR, Laza-Stanca V, Edwards MR, Walton RP, Rohde G, et al. (2009) Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 64: 375-386.